Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Regulation of activation-induced receptor activator of NF-kappaB ligand (RANKL) expression in T cells.

Wang R, Zhang L, Zhang X, Moreno J, Celluzzi C, Tondravi M, Shi Y.

Eur J Immunol. 2002 Apr;32(4):1090-8.

3.

Activated T lymphocytes support osteoclast formation in vitro.

Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT.

Biochem Biophys Res Commun. 1999 Nov;265(1):144-50.

PMID:
10548505
4.

12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.

Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.

J Bone Miner Res. 2003 Dec;18(12):2159-68.

5.

Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.

Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.

J Cell Physiol. 2004 Oct;201(1):17-25.

PMID:
15281085
8.

Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.

Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y.

J Immunol. 2000 Oct 15;165(8):4254-63.

9.

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H.

Biochem Biophys Res Commun. 2000 Sep 7;275(3):768-75.

PMID:
10973797
10.

Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression.

Wang R, Brunner T, Zhang L, Shi Y.

Oncogene. 1998 Sep 24;17(12):1503-8.

11.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
12.

Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.

Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T.

J Biol Chem. 2003 Jun 27;278(26):23971-7. Epub 2003 Apr 15.

13.

NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.

Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF.

J Biol Chem. 2007 Jun 22;282(25):18245-53. Epub 2007 May 7.

14.

Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.

Park H, Jung YK, Park OJ, Lee YJ, Choi JY, Choi Y.

J Immunol. 2005 Dec 1;175(11):7193-201.

16.

TNF-alpha expression is transcriptionally regulated by RANK ligand.

Zou W, Amcheslavsky A, Takeshita S, Drissi H, Bar-Shavit Z.

J Cell Physiol. 2005 Feb;202(2):371-8.

PMID:
15389596
18.
19.

Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.

Villalba M, Kasibhatla S, Genestier L, Mahboubi A, Green DR, Altman A.

J Immunol. 1999 Dec 1;163(11):5813-9.

20.

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.

Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T.

Nature. 2000 Nov 30;408(6812):600-5.

PMID:
11117749

Supplemental Content

Support Center